The data items required for National Cancer Data Standards for Wales – Site Specific – Skin and their equivalent labels in COSD V9.0, where there is an equivalent, are listed below.
Where the specification cites NHS Wales Data Dictionary, please refer to the Dictionary for the relevant guidance i.e. definition, format, or code list.
For consistency, all dates listed in the Specification are standardised as ccyymmdd.
Where D is denoted in Status, this indicates that the information should be derived from another data item. This typically occurs with data items that are simply text representations of their code counterparts. Other Status codes are M (Mandatory), R (Required) – the data item should be recorded where applicable and O (Optional).
Core data items should be collected for all cancers. To reduce replication of information, Core data items have not been listed in this site-specific Standard and users should refer to National Cancer Data Standards for Wales – (1. National Cancer Data Set - Full list DSCNs.xlsx (live.com) for a list of Core requirements. However, in some cases, the site-specific application of Core data items may differ e.g. a particular tumour site may require additional or fewer codes to those already published in Core, or perhaps have additional business rules as to how the Core data item should be coded. Where this occurs, the Core data item will be replicated in the site-specific Standard with the respective additional site-specific detail. These are flagged in the following table with an * next to the data item name.
For data items used in the National Cancer Data Standards for Wales that already exist within the NHS Wales Data Dictionary. These data items have been flagged with an † next to the data item name, as whilst this introduces a change to an existing information standard, the immediate use of this mandate will be used as a framework for the development of the CIS, therefore service/data providers should continue with ‘business as usual’ in terms of the data being collected and reported.
National Cancer Data Standards for Wales – Skin
Melanoma
Every new melanoma (as per CWT) will require a Core and Skin site-specific completion. Where a patient has multiple surgeries for that melanoma they should be recorded as such.
Reporting Data Item |
Definition |
Format |
Code List (Code) |
Code List (Text) |
Status |
COSD |
Skin – Clinical Examination – Malignant Melanoma. To record staging of malignant melanoma of skin | ||||||
Size of Tumour (Largest Diameter) |
Record the size of the tumour (largest diameter) as determined by the Clinician after a physical examination. Measure in centimetres (cms) |
max n2.n2 |
N/A |
N/A |
R |
N/A |
Date Draining Lymph Node Basins Examined |
Record the date that relevant draining lymph node basins were clinically examined (palpated in clinic) before WLE. Where it has been documented that the patient has no regional disease, no lymphadenopathy, or no palpable lymph nodes then this is confirmation that relevant draining lymph node basins have been examined |
ccyymmdd |
N/A |
N/A |
R |
N/A |
Skin – Diagnostic Procedures – Malignant Melanoma. To carry cancer diagnostic details for malignant melanoma of skin. (Multiple occurrences per core diagnostic procedure group) | ||||||
Grade of Clinician/Surgeon (Diagnostic Procedure) |
This is the level of training reached of the actual Clinician* or Surgeon performing the diagnostic procedure (excision or partial biopsy), and not necessarily the responsible clinician |
Code List |
NU |
Nurse |
R |
N/A |
TS |
Trainee Specialist Doctor | |||||
CS |
Consultant Surgeon (other than Plastic Surgeon/ENT Surgeon/OMF Surgeon ) | |||||
CD |
Consultant Dermatologist | |||||
CPS |
Consultant Plastic Surgeon | |||||
ENT |
Consultant ENT Surgeon | |||||
OMF |
Oral Maxillofacial (OMF) Surgeon | |||||
HP |
Hospital Practitioner/Specialty & Associate Specialist (SAS) | |||||
SI |
GP with Special Interest | |||||
GP |
General Practitioner | |||||
OO |
Other Care Professional | |||||
Biopsy Type |
Record the type of diagnostic biopsy that the patient has undergone |
Code List |
E |
Excision Biopsy |
R |
N/A |
P |
Partial Biopsy | |||||
NB |
No Biopsy | |||||
9 |
Not known | |||||
Skin – Treatment – Surgery and Other Procedures – Malignant Melanoma. To carry additional surgery details for malignant melanoma of skin. (One Occurrence per Surgical episode - all data items within this section are required) | ||||||
Grade of Clinician/Surgeon Operating |
This is the level of training reached of the actual
operating Clinician or Surgeon, and not necessarily the responsible
clinician. |
Code List |
NU |
Nurse |
R |
Grade of Clinician/Surgeon Operating (SK12010) |
TS |
Trainee Specialist Doctor | |||||
CS |
Consultant Surgeon (other than Plastic Surgeon/ENT Surgeon/OMF Surgeon ) | |||||
CD |
Consultant Dermatologist | |||||
CPS |
Consultant Plastic Surgeon | |||||
ENT |
Consultant ENT Surgeon | |||||
OMF |
Oral Maxillofacial (OMF) Surgeon | |||||
HP |
Hospital Practitioner/Specialty & Associate Specialist (SAS) | |||||
SI |
GP with Special Interest | |||||
GP |
General Practitioner | |||||
OO |
Other Care Professional | |||||
Member of Specialist MDT |
Is the actual operating Clinician or Surgeon a member of the Specialist MDT |
Code List |
Y |
Yes |
R |
Member of Specialist MDT (SK12700) |
N |
No | |||||
9 |
Not known | |||||
Depth of Excision |
At the time of definitive surgery, record the extent of
the deep excision margin in terms of tissue layers. |
Code List |
1 |
Less than deep fascia |
R |
N/A |
2 |
Down to deep fascia | |||||
8 |
Not applicable | |||||
9 |
Not recorded | |||||
Smallest Clinical Margin of Excision |
At the time of definitive surgery, record the smallest
clinically measured and documented distance to the edge of the visible
component of the excision scar/tumour from the resection margin (in
centimetres) |
Code List |
1 |
<1cm |
R |
N/A |
2 |
1- <2cm | |||||
3 |
2- <3cm | |||||
4 |
>/= 3cm | |||||
8 |
Not applicable | |||||
9 |
Not recorded | |||||
Clinical Margin |
Record the clinical margin at the time of excisional bx
prior to WLE (in millimetres). |
Code List |
1 |
<2mm |
R |
N/A |
2 |
2mm | |||||
3 |
>2mm | |||||
8 |
Not applicable | |||||
9 |
Not recorded | |||||
Skin – MDT – Malignant Melanoma. To carry additional MDT details for malignant melanoma of skin | ||||||
Tumour Resectable |
Record the decision made in MDT meeting on whether the
tumour is resectable or not. |
Code List |
Y |
Yes- resectable |
R |
N/A |
N |
No – unresectable | |||||
8 |
Not applicable | |||||
9 |
Not recorded | |||||
Skin – Treatment – Further Surgery and Other Procedures – Malignant Melanoma | ||||||
Wide Local Excision |
Has the patient undergone a wide local excision of the initial diagnostic biopsy site |
Code List |
Y |
Yes |
R |
N/A |
N |
No | |||||
8 |
Not applicable | |||||
9 |
Not known/not recorded | |||||
Pathology – Malignant Melanoma. To carry pathology details for malignant melanoma of skin. (One occurrence per Path Report) | ||||||
Skin Cancer Lesion Indicator |
This is the specimen number or letter used to identify the specimen within a report. Where more than one primary skin cancer is reported on the same pathology report, record the lesion number or letter as specified on the pathology report. |
Max an3 |
N/A |
N/A |
R |
Skin Cancer Lesion Indicator (pSK12120) |
Ulceration Indicator |
Loss of full thickness of epidermis associated with reactive changes (ulceration) |
Code List |
Y |
Yes |
R |
Ulceration Indicator (pSK12580) |
N |
No | |||||
U |
Uncertain | |||||
X |
Cannot be assessed | |||||
9 |
Not Known | |||||
Mitotic Rate (Skin) |
Mitotic Rate per square millimetres (mm) |
max n3 |
N/A |
N/A |
R |
Mitotic Rate (Skin) (pSK12590) |
Microsatellite or In-transit Metastasis Indicator |
Is there evidence of Microsatellite or in transit
metastases |
Code List |
Y |
Yes |
R |
Microsatellite or In-transit Metastasis Indicator (pSK12600) |
N |
No | |||||
U |
Uncertain | |||||
X |
Cannot be assessed | |||||
9 |
Not Known | |||||
Tumour Regression Indicator |
Area of loss of tumour associated with reactive changes |
Code List |
Y |
Yes |
R |
Tumour Regression Indicator (pSK12620) |
N |
No | |||||
U |
Uncertain | |||||
X |
Cannot be assessed | |||||
9 |
Not Known | |||||
Breslow Thickness |
Breslow Thickness in mm, can be recorded to nearest 0.01mm where clinically appropriate |
max n2.max n2 |
N/A |
N/A |
R |
Breslow Thickness (pSK12630) |
Tumour Infiltrating Lymphocytes (TILS) |
Type of TILS. Tumour infiltrating lymphocytes (TILS) are white blood cells that have left the bloodstream and migrated into a tumour |
Code List |
N |
Non-brisk |
R |
Tumour Infiltrating Lymphocytes (TILS) (pSK12430) |
B |
Brisk | |||||
A |
Absent | |||||
Sentinel Nodes Examined Number |
Number of sentinel nodes sampled |
max n2 |
N/A |
N/A |
R |
Sentinel Nodes Examined Number (pSK12460) |
Sentinel Nodes Positive Number |
Number of sentinel nodes positive |
max n2 |
N/A |
N/A |
R |
Sentinel Nodes Positive Number (pSK12470) |
Post SNB Completion Lymphadenectomy – Nodes Sampled Number |
Post Sentinel Node Biopsy (SNB) completion
lymphadenectomy, number of nodes sampled. |
max n2 |
N/A |
N/A |
R |
Post SNB Completion Lymphadenectomy – Nodes Sampled Number (pSK12480) |
Post SNB Completion Lymphadenectomy – Nodes Positive Number |
Post Sentinel Node Biopsy (SNB) completion
lymphadenectomy, number of nodes positive. |
max n2 |
N/A |
N/A |
R |
Post SNB Completion Lymphadenectomy – Nodes Positive Number (pSK12490) |
Histopathology Report Complete |
Record if all information
required in the pathology report is complete. |
Code List |
1 |
Complete |
R |
N/A |
2 |
Not Complete | |||||
8 |
Not Applicable | |||||
9 |
Not Recorded | |||||
Skin – Molecular and Biomarkers – Somatic Testing for Targeted Therapy and Personalised Therapy – Malignant Melanoma | ||||||
BRAF V600 mutation analysis of primary lesion, at diagnosis |
Record the result of BRAF V600 mutation analysis of the primary lesion at the time of diagnosis |
Code List |
1 |
Positive |
R |
N/A |
2 |
Negative | |||||
3 |
Indeterminate/Test Failed | |||||
8 |
Not Applicable (Not Tested) | |||||
9 |
Not Known | |||||
BRAF V600 mutation analysis of metastatic tissue |
Record the result of BRAF V600 mutation analysis of metastatic tissue |
Code List |
1 |
Positive |
R |
N/A |
2 |
Negative | |||||
3 |
Indeterminate/Test Failed | |||||
8 |
Not Applicable (Not Tested) | |||||
9 |
Not Known |
Cutaneous Squamous Cell Carcinoma (cSCC)
Every new cSCC (as per CWT) will require a Core and Skin site-specific completion.
Reporting Data Item |
Definition |
Format |
Code List (Code) |
Code List (Text) |
Status |
COSD |
Skin - Clinical Examination - Cutaneous Squamous Cell Carcinoma. To record staging of cutaneous squamous cell carcinoma | ||||||
Date Draining Lymph Node Basins Examined |
Record the date that relevant draining lymph node basins were clinically examined (palpated in clinic) before standard surgical excision. Where it has been documented that the patient has no regional disease, no lymphadenopathy, or no palpable lymph nodes then this is confirmation that relevant draining lymph node basins have been examined |
ccyymmdd |
N/A |
N/A |
R |
N/A |
Skin - Treatment - Surgery and Other Procedures - Cutaneous Squamous Cell Carcinoma. To carry additional surgery details for cSCC. (One Occurrence per Surgical episode - all data items within this section are required) | ||||||
Grade of Clinician/Surgeon Operating |
This is the level of training reached of the actual
operating Clinician or Surgeon, and not necessarily the responsible
clinician. |
Code List |
NU |
Nurse |
R |
Grade of Clinician/Surgeon Operating (SK12010) |
TS |
Trainee Specialist Doctor | |||||
CS |
Consultant Surgeon (other than Plastic Surgeon/ENT Surgeon/OMF Surgeon ) | |||||
CD |
Consultant Dermatologist | |||||
CPS |
Consultant Plastic Surgeon | |||||
ENT |
Consultant ENT Surgeon | |||||
OMF |
Oral Maxillofacial (OMF) Surgeon | |||||
HP |
Hospital Practitioner/Specialty & Associate Specialist (SAS) | |||||
SI |
GP with Special Interest | |||||
GP |
General Practitioner | |||||
OO |
Other Care Professional | |||||
Member of Specialist MDT |
Is the actual operating Clinician or Surgeon a member of the Specialist MDT |
Code List |
Y |
Yes |
R |
Member of Specialist MDT (SK12700) |
N |
No | |||||
9 |
Not known | |||||
Smallest Clinical Margin of Excision |
At the time of definitive surgery, record the smallest
clinically measured and documented distance to the edge of the visible
component of the excision scar/tumour from the resection margin (in
centimetres) |
Code List |
1 |
<1cm |
R |
N/A |
2 |
1- <2cm | |||||
3 |
2- <3cm | |||||
4 |
>/= 3cm | |||||
8 |
Not applicable | |||||
9 |
Not recorded | |||||
Skin - Diagnostic Procedures - Cutaneous Squamous Cell Carcinoma. To carry cancer diagnostic and prognostic details for cutaneous squamous cell carcinoma | ||||||
Risk Category |
Record the assigned risk category of patients with primary cSCC |
Code List |
1 |
Low risk |
R |
N/A |
2 |
High risk | |||||
3 |
Very high risk | |||||
9 |
Not known | |||||
Pathology - cSCC. To carry pathology details for cutaneous Squamous Cell Carcinoma. (One occurrence per Path Report) | ||||||
Skin Cancer Lesion Indicator |
This is the specimen number or letter used to identify the specimen within a report. Where more than one primary skin cancer is reported on the same pathology report, record the lesion number or letter as specified on the pathology report. |
max an3 |
N/A |
N/A |
R |
Skin Cancer Lesion Indicator (pSK12120) |
Perineural Invasion |
Is there perineural invasion (invasion into perineurium of nerve bundles- PNI) |
Code List |
Y |
Yes |
R |
Perineural Invasion (pSK12530) |
N |
No | |||||
X |
Cannot be assessed | |||||
9 |
Not Known | |||||
Lesion Diameter Greater than 20mm Indicator |
Is the diameter of the lesion greater than 20mm? |
Code List |
Y |
Yes (Greater than 20mm) |
R |
Lesion Diameter Greater than 20mm Indicator (pSK12537) |
N |
(Less than or equal to 20mm) | |||||
U |
Uncertain | |||||
X |
Cannot be assessed | |||||
9 |
Not Known | |||||
Clarks Level IV Indicator |
Greater than or equal to Clarks level IV |
Code List |
Y |
Yes |
R |
Clarks Level IV Indicator (pSK12545) |
N |
No | |||||
U |
Uncertain | |||||
X |
Cannot be assessed | |||||
Lesion Vertical Thickness Greater than 4mm Indicator |
Is the vertical thickness of the lesion greater than 4
mm |
Code List |
Y |
Yes (Greater than 4 mm) |
R |
Lesion Vertical Thickness Greater than 2mm Indicator (pSK12565) |
N1 |
No (Less than or equal to 2 mm) | |||||
N2 |
No (Greater than 2 mm but less than or equal to 4 mm) | |||||
U |
Uncertain | |||||
X |
Cannot be assessed | |||||
9 |
Not Known | |||||
Histopathology Report Complete (cSCC) |
Record if all information
required in the pathology report is complete. |
Code List |
1 |
Complete |
R |
N/A |
2 |
Not Complete | |||||
8 |
Not Applicable | |||||
9 |
Not Recorded | |||||
Skin - Post Treatment Follow Up - Cutaneous Squamous Cell Carcinoma | ||||||
Follow Up Schedule |
Record if the patient is scheduled to receive post
treatment (surgical) follow up appropriate to their risk
category |
Code List |
Y |
Yes |
R |
N/A |
N |
No | |||||
9 |
Not known/not recorded |
Basal Cell Carcinoma (BCC)
Only the first BCC should be recorded. Any subsequent occurrences, irrespective of skin location, should be added to the original (first BCC). Therefore, only one Core and Skin site-specific completion is required, however there may be multiple surgeries/paths included in that one completion to reflect subsequent lesions.
Reporting Data Item |
Definition |
Format |
Code List (Code) |
Code List (Text) |
Status |
COSD |
Skin - Diagnosis. To carry additional tumour diagnosis details for Skin. (Multiple occurrences per core diagnostic procedure group) | ||||||
Skin - Diagnosis - Basal Cell Carcinoma | ||||||
Anatomical Site of Lesion |
This is the region of the body where the lesion is present |
Code List |
1 |
Peri-Ocular |
R |
N/A |
2 |
Head and Neck | |||||
3 |
Trunk | |||||
4 |
Limbs | |||||
Skin - Treatment - Surgery and Other Procedures - Basal Cell Carcinoma. To carry additional surgery details for BCC | ||||||
Grade of Clinician/Surgeon Operating |
This is the level of training reached of the actual
operating Clinician or Surgeon, and not necessarily the responsible
clinician. |
Code List |
NU |
Nurse |
R |
Grade of Clinician/Surgeon Operating (SK12010) |
TS |
Trainee Specialist Doctor | |||||
CS |
Consultant Surgeon (other than Plastic Surgeon/ENT Surgeon/OMF Surgeon ) | |||||
CD |
Consultant Dermatologist | |||||
CPS |
Consultant Plastic Surgeon | |||||
ENT |
Consultant ENT Surgeon | |||||
OMF |
Oral Maxillofacial (OMF) Surgeon | |||||
HP |
Hospital Practitioner/Specialty & Associate Specialist (SAS) | |||||
SI |
GP with Special Interest | |||||
GP |
General Practitioner | |||||
OO |
Other Care Professional | |||||
Member of Specialist MDT |
Is the actual operating Clinician or Surgeon a member of the Specialist MDT |
Code List |
Y |
Yes |
R |
Member of Specialist MDT (SK12700) |
N |
No | |||||
9 |
Not known | |||||
Pathology - BCC. To carry pathology details for Basal Cell Carcinoma. (One occurrence per Path Report) | ||||||
Skin Cancer lesion Indicator |
This is the specimen number or letter used to identify the specimen within a report. Where more than one primary skin cancer is reported on the same pathology report, record the lesion number or letter as specified on the pathology report. |
max an3 |
N/A |
N/A |
R |
Skin Cancer Lesion Indicator (pSK12120) |
Perineural Invasion |
Is there perineural invasion (invasion into perineurium of nerve bundles- PNI) |
Code List |
Y |
Yes |
R |
Perineural Invasion (pSK12530) |
N |
No | |||||
X |
Cannot be assessed | |||||
9 |
Not Known | |||||
Lesion Diameter Greater than 20mm Indicator |
Is the diameter of the lesion greater than 20mm? |
Code List |
Y |
Yes (Greater than 20mm) |
R |
Lesion Diameter Greater than 20mm Indicator (pSK12537) |
N |
(Less than or equal to 20mm) | |||||
U |
Uncertain | |||||
X |
Cannot be assessed | |||||
9 |
Not Known |